Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 3

    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Medical Dialogues Bureau27 March 2020 9:30 AM IST
    Mumbai: Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....
    BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

    BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

    Medical Dialogues Bureau26 March 2020 12:27 PM IST
    "The export of hydroxycloroquine and formulations made from hydroxycloroquine is prohibited with immediate effect".
    Eli Lilly delays its clinical trials during Coronavirus pandemic

    Eli Lilly delays its clinical trials during Coronavirus pandemic

    Medical Dialogues Bureau25 March 2020 3:00 PM IST
    Indianapolis: Eli Lilly and Company has provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company...
    Immediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy apparatus, breathing device as well as sanitizers

    Immediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy apparatus, breathing device as well as sanitizers

    Medical Dialogues Bureau25 March 2020 1:21 PM IST
    Delhi: In its efforts to fight the COVID-19 pandemic, the Government has prohibited the export of all ventilators, including any artificial...
    Mylab gets DCGI commercial approval for COVID-19 test kit

    Mylab gets DCGI commercial approval for COVID-19 test kit

    Medical Dialogues Bureau24 March 2020 1:19 PM IST
    New Delhi: Pune-based molecular diagnostics company Mylab Discovery Solutions on Monday said it has received commercial approval from the Central...
    Cabinet nod to Rs 3000 crore for 3 Bulk Drug parks , Rs 6950 crore Production Linked Incentive Scheme for domestic production of APIs

    Cabinet nod to Rs 3000 crore for 3 Bulk Drug parks , Rs 6950 crore Production Linked Incentive Scheme for domestic production of APIs

    Medical Dialogues Bureau23 March 2020 1:22 PM IST
    Delhi: The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, India is significantly...
    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19

    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19

    Medical Dialogues Bureau22 March 2020 12:15 PM IST
    Delhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO) , Directorate General of Health Services has released the regulatory...
    Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand

    Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand

    Medical Dialogues Bureau21 March 2020 1:35 PM IST
    New Delhi: Responding to the World Health Organisation statement earlier that recommended avoidance of Ibuprofen due to its suspected worserning...
    CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studies

    CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studies

    Medical Dialogues Bureau21 March 2020 12:00 PM IST
    New Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services has clarified the...
    API should be declared strategic sector especially in light of Coronavirus: CII

    API should be declared strategic sector especially in light of Coronavirus: CII

    Medical Dialogues Bureau20 March 2020 11:00 AM IST
    New Delhi: The coronavirus outbreak makes a compelling case for the government to declare active pharmaceutical ingredient (API) as a strategic sector...
    Roche Diagnostics India first private firm to get COVID-19 test approval

    Roche Diagnostics India first private firm to get COVID-19 test approval

    Medical Dialogues Bureau20 March 2020 10:00 AM IST
    New Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit,...
    CDSCO lays down the Timeline for testing of various classes of New drugs

    CDSCO lays down the Timeline for testing of various classes of New drugs

    Medical Dialogues Bureau19 March 2020 2:33 PM IST
    New Delhi: To streamline the process of testing for approval of all categories of drugs, the Central Drugs Standard Control Organization(CDSCO),...
    PrevNext

    Popular Stories

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok